Phase I Study to Evaluate rhTPO in Healthy Caucasian Volunteers
NCT06630494
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
Recombinant human thrombopoietin for injection (rhTPO)
Sponsor
3SBIO AU PTY LTD